D.E. Shaw & Co
AURA icon

D.E. Shaw & Co’s Aura Biosciences AURA Stock Holding History

D.E. Shaw & Co’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37,883
Closed -$338K – 4403
2024
Q3 		$338K Sell
37,883
-31,616
-45% -$271K ﹤0.01% 3920
2024
Q2 		$525K Sell
69,499
-25,946
-27% -$190K ﹤0.01% 3596
2024
Q1 		$749K Buy
95,445
+35,381
+59% +$293K ﹤0.01% 3272
2023
Q4 		$532K Buy
+60,064
New +$509K ﹤0.01% 3485

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

D.E. Shaw & Co's AURA Position: Q4 2024 in Review

D.E. Shaw & Co sold out of Aura Biosciences (AURA) in Q4 2024, closing a stake of 37,883 shares — an estimated $338K sold.

D.E. Shaw & Co first reported a position in AURA in Q4 2023 and held it in 4 quarters. The position peaked at $749K in Q1 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q4 2024.

  • D.E. Shaw & Co reported no remaining Aura Biosciences position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 37,883 Aura Biosciences shares in Q4 2024, an estimated $338K.
  • D.E. Shaw & Co first reported a position in Aura Biosciences in Q4 2023 and held it in 4 quarters.
  • D.E. Shaw & Co's Aura Biosciences position peaked at $749K in Q1 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.